MedTrace Logo

Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer

NCT02188615 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-07-11

No results posted yet for this study

Summary

The primary objective is to compare neo-adjuvant chemoradiotherapy followed by Mckeown Minimally Invasive Esophagectomy (MIE) Versus Mckeown MIE, pure radical chemoradiotherapy in terms of the overall survival time (OS) in patients with Stage IIB or III squamous cell esophageal carcinoma.

Conditions

  • Squamous Cell Esophageal Carcinoma

Interventions

PROCEDURE

Neo-adjuvant Chemoradiotherapy followed by Mckeown MIE

Neo-adjuvant Chemoradiotherapy followed by Mckeown MIE

DRUG

Cisplatin

only Radical Chemoradiotherapy

DEVICE

Mckeown MIE

only Mckeown MIE using thoracoscopy and laparoscopy

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Fudan University

    collaborator OTHER

  • Chengchu Zhu

    lead OTHER

Principal Investigators

  • Cheng chu Zhu, professor · Taizhou Hospital

  • Bao fu Chen, professor · Taizhou Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-06-30
Completion
2019-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02188615 on ClinicalTrials.gov